The risk factors for diabetic foot ulceration

Foot

Volumn 13, Issue 3, 2003, Pages 125-129

  Merza, Z ^a   Tesfaye, S ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Diabetes complications; Foot ulcer; Risk factors

Indexed keywords

INSULIN;

DIABETES CONTROL; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; FOOT AMPUTATION; GENDER; HEALTH SERVICE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EID: 0042564606     PISSN: 09582592     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-2592(03)00031-2     Document Type: Review

References (38)

1. Williams G, Pickup JC. Introduction to diabetes. In: Handbook of diabetes, 2nd ed. Oxford: Blackwell; 1999. p. 2-4.
2. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressure in diabetic foot ulceration. Diabetes Care 1998;21(10):1714-9.
3. Reiber GE. The epidemiology of foot ulcers and amputations in the diabetic foot. In: Bowker JH, Pfeifer MA, editors. Levin and O'Neal's The Diabetic foot, 6th ed. St. Louis: Mosby; 2001. p. 13-32.
4. Levin ME. Foot lesions in patients with diabetes mellitus. Endocrinol Metab Clin North Am 1996;25(2):447-62.
5. Levin ME. Pathogenesis and general management of foot lesions in the diabetic patient. In: Bowker JH, Pfeifer MA, editors. Levin and O'neal's The Diabetic foot, 6th ed. St. Louis: Mosby; 2001. p. 219-60.
6. Adler AI, Boyko EJ, Ahroni EH, Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy and foot ulcers. Diabetes Care 1999;22(7):1029-35.
7. Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996;13:967-72.
8. Boulton AJM. The pathogenesis of diabetic foot problems: an overview. Diabet Med 1996;13:S12-6.
9. Kumar S, Ashe HA, Parnell LN, et al. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population based study. Diabet Med 1994;11:480-4.
10. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia 1996;39(11):1377-84.
11. Young MJ, Boulton AJM, Macload AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.
12. Sumpio BE. Foot ulcers. N Engl J Med 2000;343(11):787-93.
13. Abbott CA, Vileikyte L, Williamson S, Carrington A, Boulton AJM. Multicentre study of incidence and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care 1998;21(7): 1071-5.
14. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle diabetic foot study. Diabetes Care 1999;22(7): 1036-42.
15. Tooke JE, Brash PD. Microvascular aspects of diabetic foot disease. Diabet Med 1996;13:S26-9.
16. McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995;18(2):216-9.
17. Cavanagh PR, Ulbrecht JS, Capuyo GM. Biomechanical aspects of diabetic foot disease: aetiology, treatment and prevention. Diabet Med 1996;13:S17-22.
18. Murray HJ, Young MJ, Hollis S, Boulton AJM. The association between callus formation, high pressure and neuropathy in diabetic foot ulceration. Diabet Med 1996;13:979-82.
19. Abboud RJ, Rowley DI, Newton RW. Lower limb muscle dysfunction may contribute to foot ulceration in diabetic patients. Clin Biomech (Bristol, Avon) 2000;15(1):37-45.
20. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993;233(6):485-91.
21. Mantey I, Foster AVM, Spencer S, Edmonds ME. Why do foot ulcers recur in diabetic patients? Diabet Med 1999;16:245-9.
22. Diabetes control and complications trial research group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
23. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications with type 2 diabetes. Lancet 1998;352:837-53.
24. Klein R, Kein BE, Moss SE. Relation of glycaemic control to diabetic microvascular complications in diabetes mellitus. Ann Int Med 1996;124(1 Pt 2):90-6.
25. Reichard P. Nilsson BY, Rosenqvist U. The effect of long term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329(5):304-9.
26. Lipsky B A. Infectious problems of the foot in diabetic patients. In: Bowker JH, Pfeifer MA, editors. Levin and O'neal's The Diabetic foot, 6th ed. St. Louis: Mosby; 2001. p. 467-80.
27. Moss SE, Klein R, Klein BE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Int Med 1992;152(3):610-6.
28. Gujral JS, Mcnally PG, O'Malley BP, Burden AC. Ethnic differences in the incidence of lower extremity amputations secondary to diabetes mellitus. Diabet Med 1993;10(3):271-4.
29. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996;13:S6-11.
30. Veves A, Sarnow MR, Giurini AM, et al. Differences in joint mobility and foot pressures between black and white diabetic patients. Diabet Med 1995;123(7):585-9.
31. Coppini DV, Young PJ, Weng C, Macload AF, Sonksen PH. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet Med 1998;15:265-771.
32. Fernando DJS, Hutchinson A, Veves A, Gokal R, Boulton AJM. Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med 1991;8:223-5.
33. Thomson FJ, Masson EA. Can elderly diabetic patients co-operate with routine foot care? Age Aging 1992;21(5):333-7.
34. Ctercteko GC, Dhanendran M, Hutton WC, Le Quesne LP. Vertical forces acting on the feet of diabetic patients with neuropathic ulceration. Br J Surg 1981;68(9):608-14.
35. Cavanagh PR, Sims Jr DS, Sanders LJ. Body mass is a poor predictor of peak planter pressure in diabetic men. Diabetes Care 1991;14(8):750-5.
36. Abouaesha F, van Schie CH, Griffths CD, Young RJ, Boulton AJ. Planter tissue thickness is related to peak planter pressure in the high risk diabetic foot. Diabetes Care 2001;24(7):1270-4.
37. Lippman HI, Perotto A, Farrar R. The neuropathic foot of the diabetic. Bull NY Acad Med 1976;52(10):1152-78.
38. Macfarlane RM, Jeffcoate WJ. Factors contributing to the presentation of diabetic foot ulcers. Diabet Med 1997;14:867-70.